Biotech Values

[biomaven0]

I don't disagree with you on the issue of trials.

But I do take issue with the notion that Copaxone is easier to reverse engineer than Lovenox. Sure you can ensure you have the same distribution of molecular weights and the same basic molecular building blocks. But how would you know if say the polypetides with odd-numbered chain lengths had a different distribution of chirality than the polypetides with even-numbered chain lengths? (This is not meant as a realistic example, just an illustration of how a complex mixture of molecules could have some weird characteristic that you wouldn't necessarily know about and wouldn't even know to test for).

I'm no organic chemist, so I'm admittedly very much out of my depth here, and simply trying to apply some common sense to the problem.

Peter